National Heart, Lung and Blood Institute (US)

March 24, 2011[email protected]

Learn more about:

Pulmonary Arterial Hypertension

Related Access Program

Pfizer – Pulmonary Arterial Hypertension (PAH) Pfizer – Pulmonary Arterial Hypertension Bayer – Pulmonary arterial hypertension

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.